Supporting the equitable allocation of vaccines
Vaccines are a critical component of a holistic COVID-19 response. The first wave of vaccines will not be a silver bullet due to limited supply and logistical challenges. However, if allocated thoughtfully, they will provide additional protection for a subset of our most vulnerable populations. We are working with partners to ensure resources are equitably distributed. We seek to support coalition building with respect to last mile distribution and culturally relevant communication to facilitate adoption. We would welcome the opportunity to connect with other organizations working towards a shared vision.
Deployment and development of novel therapies
We believe the most impactful therapeutics will lessen the duration and severity of the disease during the early infection phase. We are working to speed the development and deployment of these early interventions that are both readily scalable and affordable. For this reason,we actively support the use of repurposed drugs with existing safety profiles that will likely move through trials more rapidly.